Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (2 active)
2 results
Eli Lilly and Company · Gene Therapy · Phase 2
ActiveTherapeuticStronger sources
Population
Children & adults · Cohort-specific; no overall age limit
Biallelic OTOF profound bilateral auditory neuropathy
Evidence
trial
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Details
Eli Lilly and Company · Gene Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Population
Adults · ≥18 years
Unilateral progressive vestibular schwannoma with profound loss
Evidence
trial
Confidence
90%
Indications
Vestibular SchwannomaHearing Loss
Details

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.

How records are checked